ArticleInflammopharmacology2020

Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.

Eman M Elbaz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.